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ABSTRACT
Background: Atypical presentations of cutaneous leishmaniasis include sporotrichoid 
leishmaniasis (SL), which is clinically described as a primary ulcer combined with 
lymphangitis and nodules and/or ulcerated lesions along its pathway. Aims: To assess 
the differences between patients with sporotrichoid leishmaniasis and typical cutaneous 
leishmaniasis (CL). Methods: From January 2004 to December 2010, 23 cases of SL (4.7%) 
were detected among 494 CL patients diagnosed at a reference center for the disease in Rio 
de Janeiro State, Brazil. These 23 cases were compared with the remaining 471 patients 
presenting CL. Results: SL predominated in female patients (60.9%, p = 0.024), with older 
age (p = 0.032) and with lesions in upper limbs (52.2%, p = 0.028). CL affected more men 
(64.5%), at younger age, and with a higher number of lesions exclusively in lower limbs 
(34.8%). Conclusions: Differences in clinical and epidemiological presentation were found 
between SL patients as compared to CL ones, in a region with a known predominance of 
Leishmania (Viannia) braziliensis. The results are similar to the features of most of the 
sporotrichosis patients as described in literature, making the differential diagnosis between 
ATL and sporotrichosis more important in overlapping areas for both diseases, like in Rio 
de Janeiro State. 
KEYWORDS: Sporotrichoid leishmaniasis. American tegumentary leishmaniasis. Cutaneous 
leishmaniasis. Sporotrichosis.
INTRODUCTION 
The most characteristic presentation of cutaneous leishmaniasis is: one or 
a few painless ulcers with infiltrated borders in exposed body areas1. However, 
several other forms are also described2,3. This diversity could be related to the host 
immune response, skin area, and species of Leishmania4,5. In Rio de Janeiro State, 
Leishmania (Viannia) braziliensis is the almost exclusively prevalent species4, and 
different genotypes were not associated with the clinical variability6.
Sporotrichoid leishmaniasis (SL) presents itself as an ulcer, lymphangitis, and 
nodules or ulcerated lesions along its pathway; it resembles the typical presentation 
of sporotrichosis2,5,7. This study aimed to access the differences between SL and 
typical cutaneous leishmaniasis.
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MATERIALS AND METHODS 
Cross-sec t ional  s tudy wi th  compar ison  of 
epidemiological and clinical parameters, laboratory findings 
at the time of diagnosis, as well as post-treatment follow-
up, between sporotrichoid forms of leishmaniasis (SL) and 
typical forms of cutaneous leishmaniasis (CL).
We studied patients diagnosed with American 
tegumentary leishmaniasis (ATL) at a reference center for 
the disease in Rio de Janeiro, Brazil, between January 2004 
and December 2010. 
Patients who were included followed systematic 
research protocols, including epidemiological history, 
clinical examination and laboratory tests. Patients with 
concomitant involvement of skin and mucous membranes of 
the upper aerodigestive tract and those with diffuse anergic 
leishmaniasis were excluded.
Patients were evaluated by experienced dermatologists 
in the diagnosis and treatment of cutaneous leishmaniasis. 
Clinical diagnosis of SL was performed when there 
were ulcerated lesions accompanied by lymphangitis 
and gummas/nodes along the lymphatic path. Typical 
leishmaniasis lesions (CL) were not accompanied by 
this lymphatic pattern, and were generally comprised of 
ulcerated lesions with infiltrated borders, in most cases one 
lesion or a few; occasionally, an infiltrated plaque or, more 
rarely, verrucous lesions. Patients with ten or more lesions 
were also exceptions. Cases presenting with short lymphatic 
path around the lesion without gummas or nodules were not 
clinically classified as SL.
Diagnosis of leishmaniasis was confirmed by 
visualization and/or isolation of parasites by at least one 
of the following methods: Leishmania spp culture in 
NNN+ Schneider media8, or conventional histopathology 
and/or immunohistochemical examination9 of a skin 
lesion fragment collected through a biopsy procedure. 
Immunological tests included Montenegro skin test 
(MST)10 and serological tests such as the indirect 
immunofluorescence assay (IFA), and/or the enzyme-
linked immunosorbent assay (ELISA)11.
The analysis considered clinical characteristics (gender, 
age, time of disease progression before diagnosis, affected 
area of the body, and response to treatment - cure or relapse 
of the disease), besides the results to the diagnostic exams 
listed above.
A database was constructed (SPSS16 software for 
Windows - SPSS Inc, Chicago, Illinois, USA), and kept 
under the responsibility of the authors, based on the 
records of the patients. Clinical features and the results 
of the laboratory exams of SL patients were compared 
with the same parameters of CL patients treated in the 
same period at this reference center. Measurements of 
central tendency and dispersion for quantitative variables 
(age in years, MST in millimeters, time of disease 
progression before diagnosis in months) were calculated 
and subsequently these parameters were transformed into 
categorical variables as follows:
Age: < 25 years, 25 to 44 years, > 44 years.
MST in millimeters: negative (0 to 4 mm); and positive 
(≥ 5 mm). 
Time of disease progression before diagnosis: ≤ 3 months; 
and > 3 months. 
Affected area of the body: lesions exclusively located 
in upper limbs; exclusively located in lower limbs; and in 
other or multiple locations. 
The variables were analyzed using the Pearson Chi 
Squared and Fisher’s exact tests, as well as by logistic 
regression (SPSS16.0). 
The species of Leishmania was determined in SL 
patients, whenever possible. 
Missing data were not considered in the analysis, but 
they were made explicit in Table 1. 
Ethical considerations
Patients signed an informed consent at diagnosis. This 
study is a subproject of a larger research project approved 
by the Institutional Ethics in Research Committee under 
the Nº 0016.0.009-02, and it was re-submitted to the same 
Board and revalidated under the Nº 0056.0.009.000-10. 
RESULTS
During the analyzed period, among 579 patients with 
ATL, 84 patients had mucosal involvement and one patient 
had diffuse anergic leishmaniasis and were therefore 
excluded, since they had a particular immunological 
behaviour; 494 patients with cutaneous leishmaniasis were 
studied, among them 23 (4.7%) presented SL. Figure 1 
shows lesions of patients with SL in upper limbs (upside) 
and typical CL lesions in lower limbs (bottom).
Twenty patients (86.9%) with SL had positive cultures 
for Leishmania spp, and 18 were characterized as 
L. (V.) braziliensis. From the three remaining patients, one 
had parasitologically confirmed SL through visualization 
of amastigotes in histopathology; the other two had 
SL diagnosis made through a compatible clinical and 
epidemiological history, aside from positive immunological 
tests (MST, IFA and/or ELISA), as well as a good response 
to treatment with meglumine antimoniate.
The results of the clinical and epidemiological features, 
laboratory tests performed for diagnosis, and follow-up 
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Table 1 - Clinical-epidemiological and laboratory characteristics, besides post-treatment follow-up- of patients with sporotrichoid 
leishmaniasis (SL) and typical cutaneous leishmaniasis (CL), 2004 - 2010
SL CL p-value
Gender Male 39.1% (09) 64.5% (304)
Female 60.9% (14) 35.5% (167) 0.024a
Missing data 0 0
Age (years) Mean 44.74 35.94
Standard deviation 19.010 19.073 0.906b
Minimum 13 1
Maximum 80 92
< 25 years 13.0% (03) 31.8% (150)
25 – 44 years 52.2% (12) 36.3% (171) 0.032c
> 44 years 34.8% (08) 31.8% (150)
Missing data 0 0
Time of disease 
progression before 
diagnosis (months)
Mean 2.55 3.11
Standard deviation 2.283 3.769 0.987b
Minimum 1 1
Maximum 12 53
≤ 3 months 90.9%* (20) 75.3%* (342)
> 3 months 9.1%* (02) 24.7%* (112) 0.125a
Missing data 01 17
Affected site of 
the body
Exclusively upper limbs 52.2% (12) 27.2% (128)
Exclusively lower limbs 
Other/multiple sites, with 
or without upper or lower 
limbs
17.4% (4) 
30.4% (7)
34.8% (164) 
38.0% (179)
0.028b
Montenegro skin test 
(millimeters)
Mean 21.75 18.54
Standard deviation 10.992 12.008 0.266b
Minimum 0 0
Maximum 50 75
Negative (0-4 mm) 5%* (01) 6.3%* (26)
Positive (≥ 5 mm) 95%* (19) 93.7% (384) 1.000a
Missing data 03 61
Indirect 
immunofluorescence 
assay (IFA)
Negative 41.2%* (07) 29.5%* (101)
Positive 58.8%* (10) 70.5%* (241) 0.294a
Missing data 06 129
Enzyme-linked 
immunosorbent 
assay (ELISA)
Negative 21.1%* (04) 11.6%* (35)
Positive 78.9%* (15) 88.4%* (267) 0.266a
Missing data 04 169
Culture for Leishmania Negative 13.0% (03) 14.2%* (57)
Positive 87.0% (20) 85.8%* (345) 1.000a
Missing data 0 69
Histopathology Without parasites 52.2% (12) 42.2%* (151)
With parasites 47.8% (11) 57.8%* (207) 0.389a
Missing data 0 113
Post-treatment 
follow-up
Cure 70.6%* (12) 79.4%* (274)
Re-activation 29.4%* (05) 20.3%* (70) 0.394a
Missing data 06 127
*Valid percentages, missing data cases excluded. ( ) Number of cases. aFisher’s Exact Test. bPearson Chi Square. cLogistic regres-
sion. Bold p-value statistically significant.
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after treatment for both groups of patients (SL and CL) are 
presented in Table 1. 
DISCUSSION
There were significant differences when clinical and 
epidemiological characteristics of patients with SL and CL 
were compared, with more females and older age in SL. 
Patients with CL were predominantly males, in agreement 
with data from the Ministry of Health of Brazil, which 
reported 74% of cases of cutaneous leishmaniasis in men1. 
Although in both groups the lesions were mainly detected in 
exposed areas, we observed a predominance of lesions in the 
upper limbs in the SL group, as compared to the CL group, 
which presented a higher number of lower limb lesions, 
as classically described in the literature3,12. Interestingly, 
those features were are also present in sporotrichosis in 
Rio de Janeiro, with a predominance of older females and 
lesions in the upper limbs13. They are different pathogens 
showing similar clinical-epidemiological characteristics. 
Despite diverse explanations for their occurrence, in the 
case of sporotrichosis transmitted by cats, older women are 
more likely to care for and feed infected animals, which 
could also explain why lesions are presented mostly in the 
hands and forearms/arms due to the manipulation of cats13. 
Leishmaniasis, however, is transmitted by sand flies and this 
explanation does not elucidate the results obtained in SL. 
We have generally observed that SL patients behaved 
similarly to CL patients in terms of laboratory exams, and 
did not present different post-treatment prognosis either. 
MST is a tool for evaluating the delayed hypersensitivity 
cell response to Leishmania antigens inoculated 
intradermally, and it is widely used for diagnosis and in 
epidemiological surveys10,14. Despite the fact that it does not 
constitute a confirmatory parasitological test, it is usually the 
only available diagnostic test for cutaneous leishmaniasis in 
most primary health care facilities in Brazil. The test may 
be negative in the first four to six weeks from the onset of 
skin lesions1. Additionally, positivity to MST is independent 
of gender or age of patients15, and it is reported to have a 
high sensitivity: positivity close to 100% in confirmed ATL 
cases16. However, in individuals who do not have active 
leishmaniasis, lesions or scars suggestive of prior disease, or 
in those who reside in non-endemic areas for the disease, its 
positivity may vary between 20 and 30%1,10. The occurrence 
of positive MST in confirmed cases of sporotrichosis was 
previously detected in Rio de Janeiro17. Since endemic areas 
for sporotrichosis and leishmaniasis overlap extensively 
in Rio de Janeiro State, the presence of both agents could 
partly explain the positivity of MST in patients who do not 
have leishmaniasis, adding some difficulty to the differential 
diagnosis. However, in our study, the strong reactions found 
in almost all the patients with SL lead us to suggest that this 
test can be valuable in conditions of scarcity of exams for 
Figure 1 - Sporotrichoid leishmaniasis in upper limbs (upside) and typical cutaneous leishmaniasis in lower limbs (bottom)
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the parasitological diagnosis of leishmaniasis. There was 
a trend to higher values of MST in patients with SL than 
in patients with CL. 
In patients with CL, there are also generally low to 
moderate levels of specific antibodies detected by both IFA 
and ELISA, when compared to the levels found in patients 
with the mucosal forms of the disease. However, there are 
individual variations11,18. In our study, both groups (SL and 
CL) showed moderate to high percentages of positivity in 
leishmaniasis serology by those methods. 
Regarding parasite detection by culture of fragments 
of lesions collected through biopsy, considered as the gold 
standard for ATL diagnosis, the majority of our patients 
were diagnosed based on the parasite isolation (85% in both 
SL and CL groups). This positivity is higher than usually 
described12,19. In addition, both studied groups showed 
moderate sensitivity of parasite detection in histopathology. 
Sensitivity indices of histopathology in the literature show 
wide variation1,12; however, immunohistochemistry showed 
higher sensitivities than hematoxylin-eosin staining for the 
parasite detection9.
The analyzed patients in the present study came from a 
geographical area with a large predominance of Leishmania 
(V.) braziliensis, like most of Brazilian regions. This can be 
considered a limitation of the study. In the Amazon region, for 
example, the coexistence of different species of Leishmania 
could lead to other findings. Additional studies to verify 
clinical and epidemiological features of SL patients under 
conditions of greater diversity of the parasite population can 
add information to the SL characterization. However, as SL is 
reported in other countries20-22 where L. (V.) braziliensis has 
not been reported, it seems that this clinical presentation is 
mostly due to the characteristics of the patients. In addition, 
as sporotrichosis has been described in different regions all 
over the world23-26, differential diagnosis may become a real 
challenge elsewhere.
The results of the present study suggest that SL and 
CL patients have different characteristics, and they reflect 
mainly clinical and epidemiological variations between 
the groups. Since these differences could be produced 
by distinct immunological profiles, studies are now 
been performed in order to clarify in situ immunological 
distinctions between SL and CL.
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